Acute liver dysfunction after cardiac arrest.

Few data are available regarding hypoxic hepatitis (HH) and acute liver failure (ALF) in patients resuscitated from cardiac arrest (CA). The aim of this study was to describe the occurrence of these complications and their association with outcome. All adult patients admitted to the Department of In...

Full description

Bibliographic Details
Main Authors: Enrica Iesu, Federico Franchi, Federica Zama Cavicchi, Selene Pozzebon, Vito Fontana, Manuel Mendoza, Leda Nobile, Sabino Scolletta, Jean-Louis Vincent, Jacques Creteur, Fabio Silvio Taccone
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6218055?pdf=render
_version_ 1819042815478333440
author Enrica Iesu
Federico Franchi
Federica Zama Cavicchi
Selene Pozzebon
Vito Fontana
Manuel Mendoza
Leda Nobile
Sabino Scolletta
Jean-Louis Vincent
Jacques Creteur
Fabio Silvio Taccone
author_facet Enrica Iesu
Federico Franchi
Federica Zama Cavicchi
Selene Pozzebon
Vito Fontana
Manuel Mendoza
Leda Nobile
Sabino Scolletta
Jean-Louis Vincent
Jacques Creteur
Fabio Silvio Taccone
author_sort Enrica Iesu
collection DOAJ
description Few data are available regarding hypoxic hepatitis (HH) and acute liver failure (ALF) in patients resuscitated from cardiac arrest (CA). The aim of this study was to describe the occurrence of these complications and their association with outcome. All adult patients admitted to the Department of Intensive Care following CA were considered for inclusion in this retrospective study. Exclusion criteria were early death (<24 hours) or missing biological data. We retrieved data concerning CA characteristics and markers of liver function. ALF was defined as a bilirubin >1.2 mg/dL and an international normalized ratio ≥1.5. HH was defined as an aminotransferase level >1000 IU/L. Neurological outcome was assessed at 3 months and an unfavourable neurological outcome was defined as a Cerebral Performance Categories (CPC) score of 3-5. A total of 374 patients (age 62 [52-74] years; 242 male) were included. ALF developed in 208 patients (56%) and HH in 27 (7%); 24 patients developed both conditions. Patients with HH had higher mortality (89% vs. 51% vs. 45%, respectively) and greater rates of unfavourable neurological outcome (93% vs. 60% vs. 59%, respectively) compared to those with ALF without HH (n = 184) and those without ALF or HH (n = 163; p = 0.03). Unwitnessed arrest, non-shockable initial rhythm, lack of bystander cardiopulmonary resuscitation, high adrenaline doses and the development of acute kidney injury were independent predictors of unfavourable neurological outcome; HH (OR: 16.276 [95% CIs: 2.625-81.345; p = 0.003), but not ALF, was also a significant risk-factor for unfavourable outcome. Although ALF occurs frequently after CA, HH is a rare complication. Only HH is significantly associated with poor neurological outcome in this setting.
first_indexed 2024-12-21T09:46:53Z
format Article
id doaj.art-47f314bb8aea41aaaf82c13c4e77a605
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T09:46:53Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-47f314bb8aea41aaaf82c13c4e77a6052022-12-21T19:08:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011311e020665510.1371/journal.pone.0206655Acute liver dysfunction after cardiac arrest.Enrica IesuFederico FranchiFederica Zama CavicchiSelene PozzebonVito FontanaManuel MendozaLeda NobileSabino ScollettaJean-Louis VincentJacques CreteurFabio Silvio TacconeFew data are available regarding hypoxic hepatitis (HH) and acute liver failure (ALF) in patients resuscitated from cardiac arrest (CA). The aim of this study was to describe the occurrence of these complications and their association with outcome. All adult patients admitted to the Department of Intensive Care following CA were considered for inclusion in this retrospective study. Exclusion criteria were early death (<24 hours) or missing biological data. We retrieved data concerning CA characteristics and markers of liver function. ALF was defined as a bilirubin >1.2 mg/dL and an international normalized ratio ≥1.5. HH was defined as an aminotransferase level >1000 IU/L. Neurological outcome was assessed at 3 months and an unfavourable neurological outcome was defined as a Cerebral Performance Categories (CPC) score of 3-5. A total of 374 patients (age 62 [52-74] years; 242 male) were included. ALF developed in 208 patients (56%) and HH in 27 (7%); 24 patients developed both conditions. Patients with HH had higher mortality (89% vs. 51% vs. 45%, respectively) and greater rates of unfavourable neurological outcome (93% vs. 60% vs. 59%, respectively) compared to those with ALF without HH (n = 184) and those without ALF or HH (n = 163; p = 0.03). Unwitnessed arrest, non-shockable initial rhythm, lack of bystander cardiopulmonary resuscitation, high adrenaline doses and the development of acute kidney injury were independent predictors of unfavourable neurological outcome; HH (OR: 16.276 [95% CIs: 2.625-81.345; p = 0.003), but not ALF, was also a significant risk-factor for unfavourable outcome. Although ALF occurs frequently after CA, HH is a rare complication. Only HH is significantly associated with poor neurological outcome in this setting.http://europepmc.org/articles/PMC6218055?pdf=render
spellingShingle Enrica Iesu
Federico Franchi
Federica Zama Cavicchi
Selene Pozzebon
Vito Fontana
Manuel Mendoza
Leda Nobile
Sabino Scolletta
Jean-Louis Vincent
Jacques Creteur
Fabio Silvio Taccone
Acute liver dysfunction after cardiac arrest.
PLoS ONE
title Acute liver dysfunction after cardiac arrest.
title_full Acute liver dysfunction after cardiac arrest.
title_fullStr Acute liver dysfunction after cardiac arrest.
title_full_unstemmed Acute liver dysfunction after cardiac arrest.
title_short Acute liver dysfunction after cardiac arrest.
title_sort acute liver dysfunction after cardiac arrest
url http://europepmc.org/articles/PMC6218055?pdf=render
work_keys_str_mv AT enricaiesu acuteliverdysfunctionaftercardiacarrest
AT federicofranchi acuteliverdysfunctionaftercardiacarrest
AT federicazamacavicchi acuteliverdysfunctionaftercardiacarrest
AT selenepozzebon acuteliverdysfunctionaftercardiacarrest
AT vitofontana acuteliverdysfunctionaftercardiacarrest
AT manuelmendoza acuteliverdysfunctionaftercardiacarrest
AT ledanobile acuteliverdysfunctionaftercardiacarrest
AT sabinoscolletta acuteliverdysfunctionaftercardiacarrest
AT jeanlouisvincent acuteliverdysfunctionaftercardiacarrest
AT jacquescreteur acuteliverdysfunctionaftercardiacarrest
AT fabiosilviotaccone acuteliverdysfunctionaftercardiacarrest